Report cover image

Keratosis Pilaris Treatment Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 123 Pages
SKU # APRC20352826

Description

Summary

According to APO Research, The global Keratosis Pilaris Treatment market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Keratosis Pilaris Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Keratosis Pilaris Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Keratosis Pilaris Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Keratosis Pilaris Treatment include AmLactin (Novartis), CeraVe (L'Oréal), DERMAdoctor, Eucerin (Beiersdorf AG), Excipial (Galderma), First Aid Beauty (P&G), Neutrogena (Johnson & Johnson), Nip + Fab and Paula’s Choice, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Keratosis Pilaris Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Keratosis Pilaris Treatment.
The Keratosis Pilaris Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Keratosis Pilaris Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Keratosis Pilaris Treatment Segment by Company

AmLactin (Novartis)
CeraVe (L'Oréal)
DERMAdoctor
Eucerin (Beiersdorf AG)
Excipial (Galderma)
First Aid Beauty (P&G)
Neutrogena (Johnson & Johnson)
Nip + Fab
Paula’s Choice
SLMD Skincare
Touch Skin Care
Keratosis Pilaris Treatment Segment by Type

Body Scrub
Lotion
Body Wash & Shower Gel
Other
Keratosis Pilaris Treatment Segment by Application

For Body
For Facial Skin
Keratosis Pilaris Treatment Segment by Application

For Body
For Facial Skin
Keratosis Pilaris Treatment Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Keratosis Pilaris Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Keratosis Pilaris Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Keratosis Pilaris Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Keratosis Pilaris Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

123 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Keratosis Pilaris Treatment by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Body Scrub
2.2.3 Lotion
2.2.4 Body Wash & Shower Gel
2.2.5 Other
2.3 Keratosis Pilaris Treatment by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 For Body
2.3.3 For Facial Skin
2.4 Assumptions and Limitations
3 Keratosis Pilaris Treatment Breakdown Data by Type
3.1 Global Keratosis Pilaris Treatment Historic Market Size by Type (2020-2025)
3.2 Global Keratosis Pilaris Treatment Forecasted Market Size by Type (2026-2031)
4 Keratosis Pilaris Treatment Breakdown Data by Application
4.1 Global Keratosis Pilaris Treatment Historic Market Size by Application (2020-2025)
4.2 Global Keratosis Pilaris Treatment Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Keratosis Pilaris Treatment Market Perspective (2020-2031)
5.2 Global Keratosis Pilaris Treatment Growth Trends by Region
5.2.1 Global Keratosis Pilaris Treatment Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Keratosis Pilaris Treatment Historic Market Size by Region (2020-2025)
5.2.3 Keratosis Pilaris Treatment Forecasted Market Size by Region (2026-2031)
5.3 Keratosis Pilaris Treatment Market Dynamics
5.3.1 Keratosis Pilaris Treatment Industry Trends
5.3.2 Keratosis Pilaris Treatment Market Drivers
5.3.3 Keratosis Pilaris Treatment Market Challenges
5.3.4 Keratosis Pilaris Treatment Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Keratosis Pilaris Treatment Players by Revenue
6.1.1 Global Top Keratosis Pilaris Treatment Players by Revenue (2020-2025)
6.1.2 Global Keratosis Pilaris Treatment Revenue Market Share by Players (2020-2025)
6.2 Global Keratosis Pilaris Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Keratosis Pilaris Treatment Head Office and Area Served
6.4 Global Keratosis Pilaris Treatment Players, Product Type & Application
6.5 Global Keratosis Pilaris Treatment Manufacturers Established Date
6.6 Global Keratosis Pilaris Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Keratosis Pilaris Treatment Market Size (2020-2031)
7.2 North America Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Keratosis Pilaris Treatment Market Size by Country (2020-2025)
7.4 North America Keratosis Pilaris Treatment Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Keratosis Pilaris Treatment Market Size (2020-2031)
8.2 Europe Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Keratosis Pilaris Treatment Market Size by Country (2020-2025)
8.4 Europe Keratosis Pilaris Treatment Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Keratosis Pilaris Treatment Market Size (2020-2031)
9.2 Asia-Pacific Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Keratosis Pilaris Treatment Market Size by Country (2020-2025)
9.4 Asia-Pacific Keratosis Pilaris Treatment Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Keratosis Pilaris Treatment Market Size (2020-2031)
10.2 South America Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Keratosis Pilaris Treatment Market Size by Country (2020-2025)
10.4 South America Keratosis Pilaris Treatment Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Keratosis Pilaris Treatment Market Size (2020-2031)
11.2 Middle East & Africa Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2020-2025)
11.4 Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 AmLactin (Novartis)
12.1.1 AmLactin (Novartis) Company Information
12.1.2 AmLactin (Novartis) Business Overview
12.1.3 AmLactin (Novartis) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.1.4 AmLactin (Novartis) Keratosis Pilaris Treatment Product Portfolio
12.1.5 AmLactin (Novartis) Recent Developments
12.2 CeraVe (L'Oréal)
12.2.1 CeraVe (L'Oréal) Company Information
12.2.2 CeraVe (L'Oréal) Business Overview
12.2.3 CeraVe (L'Oréal) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.2.4 CeraVe (L'Oréal) Keratosis Pilaris Treatment Product Portfolio
12.2.5 CeraVe (L'Oréal) Recent Developments
12.3 DERMAdoctor
12.3.1 DERMAdoctor Company Information
12.3.2 DERMAdoctor Business Overview
12.3.3 DERMAdoctor Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.3.4 DERMAdoctor Keratosis Pilaris Treatment Product Portfolio
12.3.5 DERMAdoctor Recent Developments
12.4 Eucerin (Beiersdorf AG)
12.4.1 Eucerin (Beiersdorf AG) Company Information
12.4.2 Eucerin (Beiersdorf AG) Business Overview
12.4.3 Eucerin (Beiersdorf AG) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.4.4 Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Product Portfolio
12.4.5 Eucerin (Beiersdorf AG) Recent Developments
12.5 Excipial (Galderma)
12.5.1 Excipial (Galderma) Company Information
12.5.2 Excipial (Galderma) Business Overview
12.5.3 Excipial (Galderma) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.5.4 Excipial (Galderma) Keratosis Pilaris Treatment Product Portfolio
12.5.5 Excipial (Galderma) Recent Developments
12.6 First Aid Beauty (P&G)
12.6.1 First Aid Beauty (P&G) Company Information
12.6.2 First Aid Beauty (P&G) Business Overview
12.6.3 First Aid Beauty (P&G) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.6.4 First Aid Beauty (P&G) Keratosis Pilaris Treatment Product Portfolio
12.6.5 First Aid Beauty (P&G) Recent Developments
12.7 Neutrogena (Johnson & Johnson)
12.7.1 Neutrogena (Johnson & Johnson) Company Information
12.7.2 Neutrogena (Johnson & Johnson) Business Overview
12.7.3 Neutrogena (Johnson & Johnson) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.7.4 Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Product Portfolio
12.7.5 Neutrogena (Johnson & Johnson) Recent Developments
12.8 Nip + Fab
12.8.1 Nip + Fab Company Information
12.8.2 Nip + Fab Business Overview
12.8.3 Nip + Fab Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.8.4 Nip + Fab Keratosis Pilaris Treatment Product Portfolio
12.8.5 Nip + Fab Recent Developments
12.9 Paula’s Choice
12.9.1 Paula’s Choice Company Information
12.9.2 Paula’s Choice Business Overview
12.9.3 Paula’s Choice Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.9.4 Paula’s Choice Keratosis Pilaris Treatment Product Portfolio
12.9.5 Paula’s Choice Recent Developments
12.10 SLMD Skincare
12.10.1 SLMD Skincare Company Information
12.10.2 SLMD Skincare Business Overview
12.10.3 SLMD Skincare Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.10.4 SLMD Skincare Keratosis Pilaris Treatment Product Portfolio
12.10.5 SLMD Skincare Recent Developments
12.11 Touch Skin Care
12.11.1 Touch Skin Care Company Information
12.11.2 Touch Skin Care Business Overview
12.11.3 Touch Skin Care Revenue in Keratosis Pilaris Treatment Business (2020-2025)
12.11.4 Touch Skin Care Keratosis Pilaris Treatment Product Portfolio
12.11.5 Touch Skin Care Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.